Minocycline Reduces the Lipopolysaccharide-Induced Inflammatory Reaction, Peroxynitrite-Mediated Nitration of Proteins, Disruption of the Blood–Brain Barrier, and Damage in the Nigral Dopaminergic System

Tomás-Camardiel, Mayka, Rite, Inmaculada, Herrera, Antonio J, de Pablos, Rocio M, Cano, Josefina, Machado, Alberto, Venero, José L·2004·Neurobiology of Disease

Cited by (203)

Items 101–200 of 203

  1. Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation
    Ying Song, Er-Qing Wei, Wei-Ping Zhang, Qiu‐Fu Ge, Jian‐Ren Liu, Mengling Wang, Xiao-Jia Huang, Xin Hu, Zhong Chen · 2006 · Brain Research
  2. Minocycline in phenotypic models of Huntington's disease
    Kadiombo Bantubungi, Carine Jacquard, Anita Greco, Annita Pintor, Abdelwahed Chtarto, Khalid Taï, Marie‐Christine Galas, Liliane Tenenbaum, Nicole Déglon, Patrizia Popoli et al. · 2004 · Neurobiology of Disease
  3. Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation‐induced cell death
    Tianya Liu, Xiaoying Yang, Long Tai Zheng, Guanghui Wang, Xue‐Chu Zhen · 2016 · Journal of Neurochemistry
  4. Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
    A. Machado, Antonio J. Herrera, Jose Luis Venero, Marti Santiago, Rocío M. de Pablos, Ruth F. Villarán, Ana M. Espinosa‐Oliva, Sandro Argüelles, M. Sarmiento, María José Delgado‐Cortés et al. · 2011 · ISRN Neurology
  5. Effect of Microglia Activation on Dopaminergic Neuronal Injury Induced by Manganese, and Its Possible Mechanism
    Mingchao Liu, Tongjian Cai, Fang Zhao, Gang Zheng, Qiang Wang, Yaoming Chen, Chuanshu Huang, Wenjing Luo, Jingyuan Chen · 2009 · Neurotoxicity Research
  6. Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration
    Kevin M. Budge, Matthew P Neal, Jason R. Richardson, Fayez F. Safadi · 2020 · Molecular Neurobiology
  7. Autophagic Impairment Contributes to Systemic Inflammation-Induced Dopaminergic Neuron Loss in the Midbrain
    Hui-fen Zheng, Yaping Yang, Li‐Fang Hu, Meixia Wang, Fen Wang, Li-dan Cao, Da Li, Chengjie Mao, Kangping Xiong, Jian-Da Wang et al. · 2013 · PLoS ONE
  8. Relevance of chronic stress and the two faces of microglia in Parkinson's disease
    Herrera, Antonio J., Espinosa-Oliva, Ana M., Carrillo-Jiménez, Alejandro, Oliva-Martín, María J., García-Revilla, Juan, García-Quintanilla, Alberto, de Pablos, Rocío M., Venero, José L. · 2015 · Frontiers in Cellular Neuroscience
  9. Tumor necrosis factor-alpha during neonatal brain development affects anxiety- and depression-related behaviors in adult male and female mice
    Shirin Babri, Mohammad-Hossein Doosti, Ali‐Akbar Salari · 2014 · Behavioural Brain Research
  10. Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases
    Lisa M. Kosloski, Duy M. Ha, Jessica A.L. Hutter-Saunders, David K. Stone, Michael R. Pichler, Ashley D. Reynolds, Howard Eliot Gendelman, Rodney Lee Mosley · 2010 · Journal of Neurochemistry
  11. Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease
    Sandro Argüelles, Jose Luis Venero, Sonia Garcia-Rodriguez, Mayka Tomás‐Camardiel, Antonio Ayala, J. Cano, Alberto Machado · 2010 · Neurochemistry International
  12. Minocycline Prevents the Impairment of Hippocampal Long-Term Potentiation in the Septic Mouse
    Koji Hoshino, Mineji Hayakawa, Yuji Morimoto · 2017 · Shock
  13. The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View
    Bianca Vezzani, Marianna Carinci, Simone Patergnani, Matteo Pasquin, Annunziata Guarino, Nimra Aziz, Paolo Pinton, Michele Simonato, Carlotta Giorgi · 2020 · Biomolecules
  14. Effect of minocycline on inflammation‐induced damage to the blood–brain barrier and white matter during development
    Helen B. Stolp, Carl Joakim Ek, Pia Annette Johansson, Katarzyna M. Dzięgielewska, Ann Potter, Mark D. Habgood, Norman Ruthven Saunders · 2007 · European Journal of Neuroscience
  15. Plant-Derived Natural Products for Parkinson’s Disease Therapy
    Tapan K. Sengupta, Jayaraman Vinayagam, Raghavendra Pratap Singh, Parasuraman Jaisankar, Kochupurackal P. Mohanakumar · 2016 · Advances in neurobiology
  16. Inhibition of Neuroinflammation Prevents Injury to the Serotonergic Network After Hypoxia-Ischemia in the Immature Rat Brain
    Julie A. Wixey, Hanna E. Reinebrant, Kathryn M. Buller · 2010 · Journal of Neuropathology & Experimental Neurology
  17. Effects of co-exposure to lead and manganese on learning and memory deficits
    Ruili Guan, Tao Wang, Xiaoru Dong, Kejun Du, Juan Li, Fang Zhao, Jie Xu, Bin Li, Gang Zheng, Xuefeng Shen et al. · 2022 · Journal of Environmental Sciences
  18. Inflammatory Animal Models of Parkinson’s Disease
    Juan García‐Revilla, Antonio J. Herrera, Rocío M. de Pablos, Jose Luis Venero · 2022 · Journal of Parkinson s Disease
  19. Why Are Some People with Lower Urinary Tract Symptoms (LUTS) Depressed? New Evidence That Peripheral Inflammation in the Bladder Causes Central Inflammation and Mood Disorders
    Francis M. Hughes, Michael R. Odom, Anissa Cervantes, Austin J. Livingston, J. Todd Purves · 2023 · International Journal of Molecular Sciences
  20. The neuroprotective efficacy of α-crystallin against acute inflammation in mice
    J. Gunasingh Masilamoni, S. Vignesh, R. Kirubagaran, E. Philip Jesudason, Jayakumar Rajadas · 2005 · Brain Research Bulletin
  21. Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death
    Francisco-José Fernández-Gómez, María Gómez-Lázaro, María Dolores Pastor, Soledad Calvo, Norberto Aguirre, María Francisca Galindo, Joaquı́n Jordán · 2005 · Neurobiology of Disease
  22. Regional difference in inflammatory response to LPS-injection in the brain: Role of microglia cell density
    Cristina Pintado, Elisa Revilla, Marisa Vizuete, Sebastián Jiménez, Luisa García-Cuervo, Javier Vitórica, Diego Ruano, Angélica Castaño · 2011 · Journal of Neuroimmunology
  23. Targeting metabolic inflammation in Parkinson’s disease: Implications for prospective therapeutic strategies
    Ming Lu, Gang Hu · 2011 · Clinical and Experimental Pharmacology and Physiology
  24. Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model
    Edel T. Kavanagh, Miguel Ángel Burguillos, Alejandro Carrillo-Jiménez, Maria José Oliva-Martín, Martiniano Santiago, Johanna Rodhe, Bertrand Joseph, Jose Luis Venero · 2015 · Aging
  25. Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease
    Marthinus Janse van Vuuren, Theo A. Nell, Jonathan Ambrose Carr, Douglas Bruce Kell, Etheresia Pretorius · 2020 · Biomolecules
  26. Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease
    Li Lü, Fengqiao Li, Xiaomin Wang · 2010 · CNS & Neurological Disorders - Drug Targets
  27. Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures
    Ana M. Espinosa‐Oliva, Rocío M. de Pablos, Manuel Sarmiento Soto, Ruth F. Villarán, Alejandro Carrillo-Jiménez, Marti Santiago, Jose Luis Venero, Antonio J. Herrera, Josefina Cano, Alberto Machado · 2014 · NeuroToxicology
  28. Minocycline Protects against Neurologic Complications of Rapid Correction of Hyponatremia
    Fabrice Gankam Kengne, Alain Soupart, Roland Pochet, Jean‐Pierre Brion, Guy Decaux · 2010 · Journal of the American Society of Nephrology
  29. Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat
    Joanna Iczkiewicz, S. Rose, P. Jenner · 2005 · European Journal of Neuroscience
  30. Preconditioning as a Potential Strategy for the Prevention of Parkinson’s Disease
    Mojtaba Golpich, Behrouz Rahmani, Norlinah Mohamed Ibrahim, Leila Dargahi, Zahurin Mohamed, Azman Ali Raymond, Abolhassan Ahmadiani · 2014 · Molecular Neurobiology
  31. Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression
    Graham W. Kay, David N. Palmer · 2013 · Journal of Neuroinflammation
  32. CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects
    F. González-Lizárraga, D. Ploper, C. Ávila, S. B. Socias, Maurício dos-Santos-Pereira, Belén Machin, E. Del-Bel, P. Michel, L. Pietrasanta, R. Raisman-Vozari et al. · 2020 · Scientific Reports
  33. Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion
    Teemu Helkamaa, Ilkka Reenilä, Raimo K. Tuominen, Seppo O. Soinila, Antti J. Väänänen, Carola Tilgmann, Pekka Veli Rauhala · 2007 · Neurochemistry International
  34. Neonatal overfeeding by small‐litter rearing sensitises hippocampal microglial responses to immune challenge: Reversal with neonatal repeated injections of saline or minocycline
    S. De Luca, I. Ziko, K. Dhuna, L. Sominsky, M. Tolcos, L. Stokes, S. Spencer · 2017 · Journal of neuroendocrinology
  35. CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations
    Sunita Kumari Yadav, Grishma N. Pawar, Praveen P. Kulkarni, Craig F. Ferris, Mansoor M. Amiji · 2018 · Journal of Pharmacology and Experimental Therapeutics
  36. Minocycline does not inhibit microglia proliferation or neuronal regeneration in the facial nucleus following crush injury
    Sarah E. Fendrick, Kelly R. Miller, Wolfgang J. Streit · 2005 · Neuroscience Letters
  37. Minocycline protects SH‐SY5Y cells from 6‐hydroxydopamine by inhibiting both caspase‐dependent and ‐independent programmed cell death
    Bernardino Ossola, Tiina A. Lantto, Katja A. Puttonen, Raimo K. Tuominen, Atso Raasmaja, Pekka T. Männistö · 2011 · Journal of Neuroscience Research
  38. Preischemic neuroprotective effect of minocycline and sodium ozagrel on transient cerebral ischemic rat model
    Sang‐In Park, Sang Kyu Park, Kyoung Sool Jang, Yong Min Han, Choong Hyeon Kim, Seok Jeon Oh · 2014 · Brain Research
  39. Nurr1 Cd11bcre conditional knockout mice display inflammatory injury to nigrostriatal dopaminergic neurons
    Jie Dong, Xinyao Liu, Yuan Yuan Wang, Huaibin Cai, Weidong Le · 2020 · Glia
  40. The role of Galectin-3 in ¿-synuclein-induced microglial activation
    Antonio Boza‐Serrano, Juan F. Reyes, Nolwen L. Rey, Hakon Leffler, Luc Bousset, Ulf J. Nilsson, Patrik Brundin, Jose Luis Venero, Miguel Ángel Burguillos, Tomas Deierborg · 2014 · Acta Neuropathologica Communications
  41. The intranigral injection of tissue plasminogen activator induced blood–brain barrier disruption, inflammatory process and degeneration of the dopaminergic system of the rat
    Ruth F. Villarán, Rocío M. de Pablos, Sandro Argüelles, Ana M. Espinosa‐Oliva, Mayka Tomás‐Camardiel, Antonio J. Herrera, Josefina Cano, Alberto Machado · 2009 · NeuroToxicology
  42. Inflamación y enfermedad de Parkinson
    Carlos Barcia, María Trinidad Herrero · 2004 · Revista de Neurología
  43. From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases
    Yumeng Zhu, Ping Xu, Xuan Huang, Shuai Wen, Li Liu, Shuai Zhang, Rui Zhao, Xiuying Hu, Guan Wang · 2022 · Frontiers in Pharmacology
  44. Studies of Depression-Related States in Animal Models of Parkinsonism
    Nicoletta Schintu, Xiaoqun Zhang, Per Svenningsson · 2012 · Journal of Parkinson s Disease
  45. Degeneration of dopaminergic neurons induced by thrombin injection in the substantia nigra of the rat is enhanced by dexamethasone: Role of monoamine oxidase enzyme
    Sandro Argüelles, Antonio J. Herrera, Eloisa Carreño‐Müller, Rocío M. de Pablos, Ruth F. Villarán, Ana M. Espinosa‐Oliva, Alberto Machado, Josefina Cano · 2009 · NeuroToxicology
  46. Inhibition of vascular adhesion protein 1 protects dopamine neurons from the effects of acute inflammation and restores habit learning in the striatum
    Serena Becchi, Alberto Buson, Bernard W. Balleine · 2021 · Journal of Neuroinflammation
  47. Zocor Forte® (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not
    Marti Santiago, Ma Carmen Hernández-Romero, Alberto Machado, Josefina Cano · 2009 · European Journal of Pharmacology
  48. Minocycline Treatment Improves Cognitive and Functional Plasticity in a Preclinical Mouse Model of Major Depressive Disorder
    Silvia Poggini, María Banqueri, Naomi Ciano Albanese, Maria Teresa Golia, Fernando Gonzàlez Ibáñez, Cristina Limatola, Martin Fuhrmann, Maciej M. Lalowski, Marie‐Ève Tremblay, Laura Maggi et al. · 2022 · Behavioural Brain Research
  49. Hippocampal Neuroprotection by Minocycline and Epigallo‐Catechin‐3‐Gallate Against Cardiopulmonary Bypass‐Associated Injury
    Aida Salameh, Anne‐Marie Einenkel, Lydia Kühne, Maria Grassl, Sandy von Salisch, Phillip Kiefer, Marcel Vollroth, Ingo Dähnert, Stefan Dhein · 2015 · Brain Pathology
  50. Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?
    Tiana F. Koukoulis, Leah C. Beauchamp, Maria Kaparakis‐Liaskos, Rachel Mai McQuade, Adityas Purnianto, David Isaac Finkelstein, Kevin Jeffrey Barnham, Laura J. Vella · 2024 · Journal of Parkinson s Disease
  51. Latroeggtoxin-VI protects nerve cells and prevents depression by inhibiting NF-κB signaling pathway activation and excessive inflammation
    Haiyan Wang, Yiwen Zhai, Zhixiang Lei, Si Chen, Minglu Sun, Panfeng Yin, Zhigui Duan, Xianchun Wang · 2023 · Frontiers in Immunology
  52. The activation of NG2 expressing cells is downstream to microglial reaction and mediated by the transforming growth factor beta 1
    Ping Xiang, Lie Zhu, Hua Jiang, Bei Ping He · 2015 · Journal of Neuroimmunology
  53. Histamine and Microglia
    Tomomitsu Iida, Kazuhiko Yanai, Takeo Yoshikawa · 2022 · Current topics in behavioral neurosciences
  54. What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
    Jinsong Xue, Keju Tao, Weijia Wang, Xiaofei Wang · 2024 · International Journal of Molecular Sciences
  55. Yeast as a model for the identification of novel survival-promoting compounds applicable to treat degenerative diseases
    Sara Verbandt, Bruno P.A. Cammue, Karin Thevissen · 2016 · Mechanisms of Ageing and Development
  56. Microglial activation induced by LPS mediates excitation of neurons in the hypothalamic paraventricular nucleus projecting to the rostral ventrolateral medulla
    Tae Hee Han, Heow Won Lee, Eun A Kang, Min Seok Song, So Yeong Lee, Pan Dong Ryu · 2021 · BMB Reports
  57. Effects of second generation tetracyclines on penicillin-epilepsy-induced hippocampal neuronal loss and motor incoordination in rats
    İsmail Yılmaz, Esat Adıgüzel, Ilgaz Akdoğan, Ertuğrul Kaya, Izzettin Hatip‐Al‐Khatib · 2006 · Life Sciences
  58. Shifting Microglial Phenotypes: Targeting Disease-Associated Microglia in Neurodegeneration
    Athira Sasidharan, Yogish Somayaji, Ronald Fernandes · 2025 · ACS Chemical Neuroscience
  59. Lipopolysaccharide-Induced Striatal Nitrosative Stress and Impaired Social Recognition Memory Are Not Magnified by Paraquat Coexposure
    CinaraLudvig Gonçalves, Danúbia Bonfanti Santos, Sthéfani Spricigo Portilho, Mark William Lopes, Heloisa Ghizoni, Viviane de Souza, Josiel Mileno Mack, Aline Aita Naime, Alcir Luiz Dafré, Patrícia S. Brocardo et al. · 2018 · Neurochemical Research
  60. The Biological Changes of Synaptic Plasticity in the Pathological Process of Sepsis-associated Encephalopathy
    Lin Yang, Jin Li, Fuhong Liu, Xin Chai, Zongping Fang, Xijing Zhang · 2024 · Current Neuropharmacology
  61. Neuroinflammatory reactions in sickness behavior induced by bacterial infection: Protective effect of minocycline
    Hanaa A. Mansour, Wedad Abdallah Hassan, Gehan S. Georgy · 2017 · Journal of Biochemical and Molecular Toxicology
  62. Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss
    Dae‐Yong Song, Ha-Nul Yu, Chae-Ri Park, Jin-Sook Lee, Ji‐Yong Lee, Byung-Gu Park, Ran‐Sook Woo, Jung-Tae Han, Byung‐Pil Cho, Tai‐Kyoung Baik · 2013 · BMC Neuroscience
  63. Activation and polarization of striatal microglia and astrocytes are involved in bradykinesia and allodynia in early-stage parkinsonian mice
    Xue Zhang, Zi-Lin Shen, Ya-Wei Ji, Cui Yin, Cheng Xiao, Chunyi Zhou · 2023 · Fundamental Research
  64. Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer’s Disease
    James G. McLarnon · 2019 · Current Alzheimer Research
  65. Minocycline fails to improve neurologic and histologic outcome after ventricular fibrillation cardiac arrest in rats
    Andreas Janata, Ingrid Anna Maria Magnet, Kristin L. Schreiber, Caleb D. Wilson, Jason P. Stezoski, Keri L. Janesko‐Feldman, Patrick Michael Kochanek, Tomáš Drábek · 2019 · World Journal of Critical Care Medicine
  66. Astrocytes and their participation in the mechanisms of therapeutic action of MSC in ischemic brain injury
    Yu A Kalinina, E. G. Gilerovich, Dmitriy E. Korzhevsky · 2019 · Genes and Cells
  67. Neuroinflammation as an Integral Component of Neurodegeneration in Parkinson's Disease
    Zaynutdinkhuzha F. Sayfitdinkhuzhaev, N. Zhukova, A. N. Baidanova · 2024 · Personalized Psychiatry and Neurology
  68. Probiotics in Health and Immunity: A First Step toward Understanding the Importance of Microbiota System in Translational Medicine
    Ciro Gargiulo Isacco, Andrea Ballini, Danila De Vito, Angelo Michele Inchingolo, Stefania Cantore, Gregorio Paduanelli, Kieu Cao Diem Nguyen, Alessio Danilo Inchingolo, Gianna Dipalma, Francesco Inchingolo · 2019 · IntechOpen eBooks
  69. ¿Es la vieja minociclina un nuevo fármaco neuroprotector?
    Raquel M. Melero-Fernández de Mera, Eva García Martínez, Francisco-José Fernández-Gómez, Jesús Miguel Hernández-Guijo, Norberto Aguirre, María Francisca Galindo, Joaquín Jordán Bueso · 2008 · Revista de Neurología
  70. Current concepts on the etiology and pathogenesis of Parkinson disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett · 2011 · Elsevier eBooks
  71. Roles of Microglia in Inflammation-Mediated Neurodegeneration: Models, Mechanisms, and Therapeutic Interventions for Parkinson's Disease
    Hui‐Ming Gao, Dezhen Tu, Yun Gao, Qiyao Liu, Ru Yang, Yue Liu, Tian Guan, Jau‐Shyong Hong · 2017 · Advances in neurotoxicology
  72. The Role of the Neuropeptide Substance P in the Pathogenesis of Parkinson’s Disease
    Emma Thornton, Robert Vink · 2012 · InTech eBooks
  73. Indomethacin augments lipopolysaccharide-induced expression of inflammatory molecules in the mouse brain
    Mona Yasin Mohamed, Willias Masocha · 2020 · PeerJ
  74. Efficacy of Anti-Inflammatory Treatment in Depression
    Ole Köhler‐Forsberg, Michael E. Benros · 2018 · Elsevier eBooks
  75. Mikrobiom und neurodegenerative Erkrankungen
    Christiane Frahm, Otto Wilhelm Witte · 2019 · Die Gastroenterologie
  76. Lipopolysaccharide Aggravates Cerebral Pathology in B10.PL-derived CD1-/-,β2m-/-, TCRα-/-, and TCRδ-/- Knockout Mice
    Piotr Sura, Zbigniew Srebro, Barbara Macura, Monika Majewska, Katarzyna Zając, Marian Szczepanik · 2006 · Folia Biologica
  77. Prebiotics and Probiotics
    Dugeshwar Karley, Kush Kumar Nayak, Varaprasad Kolla · 2024 · CRC Press eBooks
  78. Interconnected roles of astrocytes and the blood–brain barrier in Parkinson’s disease: pathological evidence, mechanistic insights, and knowledge gaps
    Anna C. Stoll, Ashley S. Harms · 2026 · Frontiers in Aging Neuroscience
  79. Aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microglia
    Gamze Özata, Rachel M. Wise, Aida Cardona-Alberich, Naiyareen F. Mayeen, Stephan A. Müller, Stefan F. Lichtenthaler, Luigi Zecca, Lena F. Burbulla · 2026 · Scientific Reports
  80. STRESS AND INFLAMMATION: A DETRIMENTAL COMBINATION IN THE DEVELOPMENT OF NEURODEGENERATIVE DISEASE.
    Rocío M. de Pablos, Ana M. Espinosa‐Oliva, Manuel Sarmiento Soto, Jose Luis Venero · 2014 · Inflammation and Cell Signaling
  81. Minocycline exerts a neuroprotective action against 6-OHDA-induced neurotoxicity: in vivo and in vitro studies
    Pollyanna Landim Falcão Tavares Ferreira, Glauce Socorro de Barros Viana · 2015 · Neurology and Neuroscience
  82. Deciphering motor dysfunction and microglial activation in mThy1-α-synuclein mice: a comprehensive study of behavioral, gene expression, and methylation changes
    Brett A. McGregor, Md. Obayed Raihan, Afrina Brishti, Junguk Hur, James E. Porter · 2025 · Frontiers in Molecular Neuroscience
  83. Configuration of crosslinked multi-polymeric multi-units for site-specific delivery of nicotine
    Neha Atulkumar Singh · 2008 · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
  84. Current Concepts on the Etiology and Pathogenesis of Parkinson Disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett, Peter G. Jenner · 2007 · Elsevier eBooks
  85. Place de l'activation microgliale associée à la dégénérescence des neurones dopaminergiques provoquée par la 6-OHDA chez le rat : implication dans la compréhension de la pathogénie de la maladie de Parkinson
    Vincent Henry · 2008 · OpenGrey (Institut de l'Information Scientifique et Technique)
  86. Inflammation in Parkinson’s Disease: Causes and Consequences
    Mathé Louise, André Toulouse, M. Yvonne · 2012 · InTech eBooks
  87. Mechanisms of dopaminergic neurotoxin-induced blood-brain barrier disruption
    Niccole J. Larsen · 2007 · D-Scholarship@Pitt (University of Pittsburgh)
  88. THE ROLE OF CATECHOL-O-METHYLTRANSFERASE (COMT) AND THE EFFECTS OF COMT INHIBITION IN BRAIN AND IN CARDIOVASCULAR AND RENAL PATHOPHYSIOLOGY
    Teemu Helkamaa · 2007 · Työväentutkimus Vuosikirja
  89. Minocycline: A Reasonable Choice for Combination Therapy in Management of Pharmacoresistant Epilepsy
    Hamed Ghavimi, Esmael Izadpanah, Kambiz Hassanzadeh · 2011
  90. ROLE OF MICROGLIA DURING MOTONEURON REGENERATION AND DEGENERATION: RELEVANCE FOR PATHOGENESIS AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
    Sarah E. Fendrick · 2006
  91. Review Inflammation and infection in Parkinson's disease
    Hiroyuki Arai, Tsuyoshi Furuya, Yoshikuni Mizuno, Hideki Mochizuki · 2006
  92. Anti-inflammatory Agents for the Treatment of Depression in the Light of Comorbid Cardiovascular Disease
    Ole Köhler‐Forsberg, Christiane Gasse · 2016 · Springer eBooks
  93. Minocycline in Cerebral Ischemia and Excitotoxicity
    Jari Koıstınaho, Milla Koistinaho · 2006 · Springer eBooks
  94. Role of Primed Microglia in the Aging Brain in Prolonged Sickness and Depressive Behavior Concomitant with Peripheral Immune Stimulation
    Christopher John Henry · 2011 · OhioLink ETD Center (Ohio Library and Information Network)
  95. Inflammation-Mediated Neurodegeneration: Models, Mechanisms, and Therapeutic Interventions for Neurodegenerative Diseases
    Hui‐Ming Gao, Yun Gao, Dezhen Tu, Yue Liu, Hui Zhou, Jau‐Shyong Hong · 2017 · Wiley-VCH eBooks
  96. Neuroinflammation modifying approaches in Parkinsons disease
    Dilara Nemutlu Samur, Gül Özbey · 2018 · The Journal of Neurobehavioral Sciences
  97. Neuroinflammation potentates the degenerative effects of environmental toxins upon the substantia nigra pars compacta: a role for pro-inflammatory cytokines
    Emily N. Mangano · 2006
  98. Minocycline treatment affects astrocyte – microglia – neuron interaction and functional compensation of motor deficits in rat model of combined fluorocitrate and 6-OHDA lesion and early Parkinson’s disease
    Katarzyna Z. Kuter, Agnieszka M. Chwastek, Martyna Paleczna, Justyna Kadłuczka, Barbara Kosmowska, Innesa Leonovich, Wiktoria Maciasz, Tomasz Lenda, Joanna Kula · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Multiomic profiling reveals aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microglia
    Gamze Özata, Rachel M. Wise, Aida Cardona‐Alberich, Naiyareen Fareeza Mayeen, Stephan A. Müller, Stefan F. Lichtenthaler, Luigi Zecca, Lena F. Burbulla · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Modulation of microglia-T cell interaction as treatment of Parkinson's disease
    Kirsten Szklany · 2013 · Utrecht University Repository (Utrecht University)